A detailed history of International Assets Investment Management, LLC transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, International Assets Investment Management, LLC holds 4,020 shares of TSHA stock, worth $7,999. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,020
Previous 2,000 101.0%
Holding current value
$7,999
Previous $4.48 Million 55.36%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$2.01 - $2.46 $4,060 - $4,969
2,020 Added 101.0%
4,020 $2 Million
Q2 2024

Jul 30, 2024

BUY
$2.04 - $4.17 $4,080 - $8,340
2,000 New
2,000 $4.48 Million

Others Institutions Holding TSHA

About Taysha Gene Therapies, Inc.


  • Ticker TSHA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,359,500
  • Market Cap $96.2M
  • Description
  • Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...
More about TSHA
Track This Portfolio

Track International Assets Investment Management, LLC Portfolio

Follow International Assets Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.